nonprofit logo

National Brain Tumor Society Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 043068130 ✦ Newton, MA ✦ Designated as a 501(c)(3)

Overview

What is National Brain Tumor Society Inc?

The National Brain Tumor Society Inc, located at 55 Chapel Street, Newton, Massachusetts, is a dedicated nonprofit organization with a mission to advance brain tumor research and ultimately discover a cure. With a team of 51 employees, they have a rich history of funding groundbreaking discoveries and currently invest in innovative team-science initiatives. Their Defeat Brain Tumors program, which includes collaborations among world-renowned institutions, aims to accelerate research progress by promoting data sharing and industry partnerships. The NBTS Brain Tumor Investment Fund fosters collaboration between academic research and industrial development. Through their Research Roundtable program, they bring together stakeholders to tackle challenges and opportunities in brain tumor treatment development. The society remains committed to investing, mobilizing, and uniting their community to discover a cure, deliver effective treatments, and advocate for patients and care partners.


Official website here: www.braintumor.org

Is National Brain Tumor Society Inc legitimate?

National Brain Tumor Society Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. National Brain Tumor Society Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $496,682
Professional Fundraising Fees: $0
Other Salaries and Wages: $3,792,198

For more financial information, click here


Official website here: www.braintumor.org

What is the mission statement of National Brain Tumor Society Inc?

The National Brain Tumor Society unwaveringly invests in brain tumor research, mobilizes the community, and unites efforts to discover a cure and deliver effective treatments for adults and children afflicted by this condition. Their historic funding has contributed to groundbreaking discoveries that have advanced brain tumor research, and today, they support innovative team-science initiatives to translate discoveries into transformative medical breakthroughs. The "Defeat" program, a collaborative effort with renowned institutions, aims to accelerate research by requiring data sharing and partnerships with industry. The NBTS Brain Tumor Investment Fund bridges the gap between promising academic research and industrial development. The Research Roundtable program brings stakeholders together to tackle barriers and opportunities for advancing brain tumor treatment development.


Official website here: www.braintumor.org

Who is the CEO of National Brain Tumor Society Inc?

David Arons is the Ceo of National Brain Tumor Society Inc. The CEO's salary of National Brain Tumor Society Inc is $239,793 and their total compensation is $280,610.


Official website here: www.braintumor.org

What is the revenue of National Brain Tumor Society Inc?

National Brain Tumor Society Inc's revenue in 2022 was $13,224,585.


Official website here: www.braintumor.org

Who are the executives of National Brain Tumor Society Inc and what are their salaries?

The average compensation at National Brain Tumor Society Inc during 2022 was $84,096. There are 51 employees and 38,364 volunteers at National Brain Tumor Society Inc.

Here are 29 key members and their salaries (National Brain Tumor Society Inc's CEO's salary is $239,793 and their total compensation is $280,610):

    David Arons (Ceo)
  • Compensation: $239,793
  • Related: $0
  • Other: $40,817

    • Lauren Hall (Cso/Cdo)
  • Compensation: $246,411
  • Related: $0
  • Other: $7,670

    • Kirk Tanner (Cso)
  • Compensation: $203,236
  • Related: $0
  • Other: $11,396

    • Ashley Brennan (Exec. Dir, Peer-To-Peer Fundraising)
  • Compensation: $169,621
  • Related: $0
  • Other: $32,002

    • Kevin Jeans (Assistant Chief Development Officer)
  • Compensation: $195,290
  • Related: $0
  • Other: $5,897

    • Dorothy Whalen (Cfo)
  • Compensation: $152,540
  • Related: $0
  • Other: $15,891

    • Katie Germain (Chief Marketing & Comm. Officer)
  • Compensation: $146,080
  • Related: $0
  • Other: $4,728

    • Kenneth Troshinsky (Cfo (Until 2/2022))
  • Compensation: $45,601
  • Related: $0
  • Other: $2,040

    • Tom Roloff (Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Burger (Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dave Brown (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Liz Salmi (Clerk) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Eric Olson Phd (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dr Evanthia Galanis (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Corrao (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Salo Zelermyer Jd (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Erica Birke (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Ryan Lang (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Allison Bishof (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dr Edjah Nduom (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dr Joohee Sul (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Corie Yutkin (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Adam Hayden (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mil Parekh (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Leah Recht Jd (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kabir Sethi (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Frank Macchiarola (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David Donabedian (Board Member (Until 6/2022)) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael Smith (Board Member (Until 5/2022)) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.braintumor.org

    Where can I find the form 990 for National Brain Tumor Society Inc?

    The National Brain Tumor Society Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.braintumor.org

    Learn more at the official website: www.braintumor.org

    Mission Statement of National Brain Tumor Society Inc

    The National Brain Tumor Society, a pioneering organization, is unwavering in its commitment to investing in, mobilizing, and uniting the community to discover a cure for brain tumors. With a rich history of funding groundbreaking research, the Society today continues to fund innovative team-science initiatives designed to translate discoveries into transformative medical breakthroughs for both adults and children diagnosed with brain tumors.

    The Society's "Defeat Brain Tumors" program brings together esteemed research institutions, requiring data sharing and partnerships with industry to accelerate the pace of research. The NBTS Brain Tumor Investment Fund bridges promising academic research and moves it into industrial development, catalyzing the brain tumor biotech and biopharma space. Moreover, the NBTS Research Roundtable Program gathers stakeholders to address barriers and opportunities to brain tumor treatment development.

    Throughout its history, the National Brain Tumor Society has been instrumental in driving some of the most impactful discoveries that have advanced brain tumor research. The Society's mission remains unchanged, with a determined focus on discovering a cure, delivering effective treatments, and advocating for patients and their care partners.

    Impact

    This information is meant to be a general summary of National Brain Tumor Society Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    National Brain Tumor Society Inc unrelentingly invests in, mobilizes, and unites our community to discover a cure, deliver effective treatments, and advocate for patients and care partners. The organization funds innovative team-science initiatives, including projects in their Defeat Brain Tumors program portfolio, aimed at translating discoveries into transformative medical breakthroughs for adults and children with brain tumors. They bring together world-renowned institutions to accelerate research by requiring data sharing and partnerships with industry. Additionally, the National Brain Tumor Society's Brain Tumor Investment Fund catalyzes the brain tumor biotech and biopharma space, bridging promising academic research into industrial development. Their Research Roundtable program convenes stakeholders to address barriers and opportunities in brain tumor treatment development. The impact of this organization is vital in advancing brain tumor research, treatments, and advocacy efforts.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $-18,394
  • Program Service Revenue: $0
  • Gross Receipts: $13,311,345

    • Assets and Liabilities:
  • Total Assets: $15,423,168
  • Total Liabilities: $1,240,860
  • Net Assets: $14,182,308
  • Organization Details

    Founding Year

    1989

    Principal Officer

    David Arons

    Main Address

    55 CHAPEL STREET 006, NEWTON, MA, 02458

    NTEE Category

    Code: G40 - Disease

    If you are a representative of National Brain Tumor Society Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.